| 2/9/2026 | IG | Lilly to acquire Orna Therapeutics for up to $2.4 billion cash
|
| 12/12/2025 | GNIG | Moody's gives Eli Lilly positive view
|
| 2/10/2025 | IG | New Issue: Eli Lilly prices $6.5 billion six-tranche note sale
|
| 2/10/2025 | GNIG | Moody's assigns Eli Lilly notes Aa3
|
| 2/7/2025 | GNIG | Moody's boosts Eli Lilly
|
| 8/12/2024 | GNIG | S&P assigns Eli Lilly notes A+
|
| 8/12/2024 | GNIG | Moody's rates Eli Lilly notes A1
|
| 4/30/2024 | GNIG | Moody’s changes Eli Lilly view
|
| 5/11/2023 | GNIG | Moody's upgrades Eli Lilly
|
| 2/23/2023 | GNIG | Moody’s gives Eli Lilly notes A2
|
| 9/21/2021 | IGLM | Eli Lilly gives pricing, early results of cash tender offer for up to $1.5 billion of notes
|
| 9/21/2021 | IGLM | Eli Lilly gives early results for tender offer for up to $1.5 billion
|
| 9/7/2021 | IGLM | Eli Lilly begins tender for up to $1.5 billion notes from 15 series
|
| 8/20/2020 | IG | S&P gives Eli Lilly notes A+
|
| 8/20/2020 | IG | Moody's rates Eli Lilly notes A2
|
| 8/20/2020 | IG | Eli Lilly offers notes in two parts, including tap of notes due 2050
|
| 4/24/2020 | IG | Moody's gives Eli Lilly's notes A2
|
| 11/7/2019 | IGLM | Eli Lilly gives early results, pricing of capped tender for 15 series
|
| 11/7/2019 | IGLM | Eli Lilly gives early results of capped tender for 15 series of notes
|
| 10/24/2019 | IGLM | Eli Lilly tenders for up to $2 billion of notes from 15 series
|
| 2/20/2019 | IG | Moody's rates Eli Lilly notes A2
|
| 2/20/2019 | IG | Market Commentary: Morning Commentary: Verizon, CBS, Eli Lilly, Hudson Pacific, Whirlpool, BNG, KfW on tap
|
| 1/10/2019 | IG | Fitch affirms Eli Lilly
|
| 1/7/2019 | IG | Moody's affirms Eli Lilly on acquisition news
|
| 5/4/2017 | IG | Market Commentary: Morning Commentary: Apple, Eli Lilly, EnLink market notes; Apple weakens in secondary trading
|
| 1/19/2017 | IG | Moody’s: Eli Lilly unaffected by acquisition
|
